<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Wednesday January 7th 2026 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2026-01-07" ></link>
<id>urn:uuid:1a8bef5e-c257-ad7b-2586-6705484daf6b</id>
<updated>2026-09-19T10:33:38-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ABOS: ZUGA MATT (CFO) Sold (AS) 14,905 Shares of ACUMEN PHARMACEUTICALS INC for $1.96-$1.99 on 1/5-1/7</title>
<link href="http://www.insiderinsights.com/company/abos/acumen-pharmaceuticals-inc/id-6305521" ></link>
<id>urn:uuid:6ee3b6c5-8668-7f08-f533-0dda843a5632</id>
<updated>2026-01-07T21:31:50-05:00</updated>
<summary type="html" ><![CDATA[ACUMEN PHARMACEUTICALS INC (ABOS). Recent Price: $2.65. Mkt Cap:191.6mm. 10D Vol: 433,110]]></summary>
</entry>
<entry>
<title>ABOS: SIEMERS ERIC (O) Sold (AS) 10,834 Shares of ACUMEN PHARMACEUTICALS INC for $1.96-$1.97 on 1/5-1/6</title>
<link href="http://www.insiderinsights.com/company/abos/acumen-pharmaceuticals-inc/id-6305513" ></link>
<id>urn:uuid:48b5108e-1f0a-e97c-99c5-556b44a2cc9b</id>
<updated>2026-01-07T21:31:31-05:00</updated>
<summary type="html" ><![CDATA[ACUMEN PHARMACEUTICALS INC (ABOS). Recent Price: $2.65. Mkt Cap:191.6mm. 10D Vol: 433,110]]></summary>
</entry>
<entry>
<title>ABOS: OCONNELL DANIEL JOSEPH (CEO,DIR) Sold (AS) 47,506 Shares of ACUMEN PHARMACEUTICALS INC for $1.97-$1.99 on 1/5-1/7</title>
<link href="http://www.insiderinsights.com/company/abos/acumen-pharmaceuticals-inc/id-6305516" ></link>
<id>urn:uuid:835918fd-0a83-4cec-dd0d-cc5caf910179</id>
<updated>2026-01-07T21:31:07-05:00</updated>
<summary type="html" ><![CDATA[ACUMEN PHARMACEUTICALS INC (ABOS). Recent Price: $2.65. Mkt Cap:191.6mm. 10D Vol: 433,110]]></summary>
</entry>
<entry>
<title>ABOS: MEISNER DEREK M (LO,SEC) Sold (AS) 26,668 Shares of ACUMEN PHARMACEUTICALS INC for $1.96-$1.99 on 1/5-1/7</title>
<link href="http://www.insiderinsights.com/company/abos/acumen-pharmaceuticals-inc/id-6305511" ></link>
<id>urn:uuid:4b91a1db-9f9a-87a5-ad49-cc1f6e14e1d3</id>
<updated>2026-01-07T21:30:43-05:00</updated>
<summary type="html" ><![CDATA[ACUMEN PHARMACEUTICALS INC (ABOS). Recent Price: $2.65. Mkt Cap:191.6mm. 10D Vol: 433,110]]></summary>
</entry>
<entry>
<title>ABOS: BARTON RUSSELL (COO) Sold (AS) 9,318 Shares of ACUMEN PHARMACEUTICALS INC for $1.96-$1.99 on 1/5-1/7</title>
<link href="http://www.insiderinsights.com/company/abos/acumen-pharmaceuticals-inc/id-6305512" ></link>
<id>urn:uuid:a10ec37e-fabd-1f26-3fd5-e235b30c6941</id>
<updated>2026-01-07T21:30:15-05:00</updated>
<summary type="html" ><![CDATA[ACUMEN PHARMACEUTICALS INC (ABOS). Recent Price: $2.65. Mkt Cap:191.6mm. 10D Vol: 433,110]]></summary>
</entry>
<entry>
<title>ADPT: LO FRANCIS (HR) Sold (AS) 4,394 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $17.50 on 12/22</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6305494" ></link>
<id>urn:uuid:72e55d04-22fa-b969-82b2-7771544fac78</id>
<updated>2026-01-07T20:52:30-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $28.61. Mkt Cap:4.6B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>ADPT: LO FRANCIS (HR) Exercised 4,394 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $3.99 on 12/22, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6305495" ></link>
<id>urn:uuid:d8a71f28-32c8-b523-4f28-55c4e0021a4d</id>
<updated>2026-01-07T20:52:30-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $28.61. Mkt Cap:4.6B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>ADPT: ROBINS CHAD M (CEO,CB,DIR) Sold (AS) 124,998 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $15.59 on 1/5</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6305490" ></link>
<id>urn:uuid:160ae166-5b4f-7f4e-8c1c-f1cc716f6093</id>
<updated>2026-01-07T20:30:17-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $28.61. Mkt Cap:4.6B. 10D Vol: 2.3mm]]></summary>
</entry>
<entry>
<title>AEE: ENGSTROM JAMIE L (DIR) Acquired (JB) 1,686 Shares of AMEREN CORP for $0.00 on 1/5</title>
<link href="http://www.insiderinsights.com/company/aee/ameren-corp/id-6305425" ></link>
<id>urn:uuid:0a96c79c-e9f8-fff5-5822-f08a19e5b751</id>
<updated>2026-01-07T19:42:04-05:00</updated>
<summary type="html" ><![CDATA[AMEREN CORP (AEE). Recent Price: $102.23. Mkt Cap:28.3B. 10D Vol: 1.7mm]]></summary>
</entry>
<entry>
<title>AEE: LIPSTEIN STEVEN H (DIR) Acquired (JB) 1,686 Shares of AMEREN CORP for $0.00 on 1/5</title>
<link href="http://www.insiderinsights.com/company/aee/ameren-corp/id-6305416" ></link>
<id>urn:uuid:6252d5aa-27d6-b0c2-fe89-3727e1b37f14</id>
<updated>2026-01-07T19:41:33-05:00</updated>
<summary type="html" ><![CDATA[AMEREN CORP (AEE). Recent Price: $102.23. Mkt Cap:28.3B. 10D Vol: 1.7mm]]></summary>
</entry>
</feed>